Insmed (INSM) Operating Expenses (2010 - 2026)

Insmed has reported Operating Expenses for 17 years, with the latest figure at $427.0 million in Q2 2026.

• On a quarterly basis, Operating Expenses rose 1.6% year-over-year to $427.0 million in Q2 2026; TTM through Jun 2026 was $2.0 billion, a 41.01% increase from a year earlier, with the FY2025 full-year figure at $1.9 billion, up 49.22% from the prior year.
• Operating Expenses was $427.0 million for Q2 2026 at Insmed, down from $459.3 million in the prior quarter.
• The five-year high for Operating Expenses was $583.6 million in Q4 2025, with the low at $142.9 million in Q1 2022.
• Average Operating Expenses over 5 years is $316.6 million, with a median of $309.8 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2026: Operating Expenses surged 103.7% in 2023, then gained 1.6% in 2026.
• Over 5 years, Operating Expenses stood at $210.8 million in 2022, then climbed by 24.29% to $262.0 million in 2023, then climbed by 27.82% to $334.9 million in 2024, then surged by 74.28% to $583.6 million in 2025, then retreated by 26.83% to $427.0 million in 2026.
• The last three Operating Expenses figures came in at $427.0 million (Q2 2026), $459.3 million (Q1 2026), and $583.6 million (Q4 2025), per Business Quant data.